These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25673182)
1. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line. Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182 [TBL] [Abstract][Full Text] [Related]
2. [miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells]. Wang C; Ouyang Y; Lu M; Wei J; Zhang H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):736-9. PubMed ID: 26062412 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
4. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein. Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202 [TBL] [Abstract][Full Text] [Related]
6. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells. Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518 [TBL] [Abstract][Full Text] [Related]
7. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator. Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039 [TBL] [Abstract][Full Text] [Related]
8. Specific block of androgen receptor activity by antisense oligonucleotides. Hamy F; Brondani V; Spoerri R; Rigo S; Stamm C; Klimkait T Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061 [TBL] [Abstract][Full Text] [Related]
9. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502 [TBL] [Abstract][Full Text] [Related]
10. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
12. Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP. Zhao H; Zhu C; Qin C; Tao T; Li J; Cheng G; Li P; Cao Q; Meng X; Ju X; Shao P; Hua L; Gu M; Yin C Biochem Biophys Res Commun; 2013 Mar; 432(2):320-5. PubMed ID: 23399562 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058 [TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Wang LG; Ossowski L; Ferrari AC Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193 [TBL] [Abstract][Full Text] [Related]
18. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
19. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer. Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]